ViaLase uses an image-guided femtosecond laser surgical system for the treatment of glaucoma.
ViaLase
Aliso Viejo, CA
CEO: Tibor Juhasz, PhD
Arboretum Lead: Tim Petersen
ViaLase
IN THE NEWS
ViaLase Receives CE Mark for First Femtosecond Laser for the Treatment of Glaucoma, the ViaLase® Laser
ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm, today announced that it has received CE (Conformité Européenne) Mark approval in the…
Read More
ViaLase Closes $40M Series C Financing to Advance First Femtosecond Laser for the Treatment of Glaucoma
ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm, today announced that it has closed a Series C financing raising gross…
Read More
